EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1

Active Implantable Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 90/385/EEC on Active Implantable Medical Devices, 20 July 1990, amended by Directive 2007/47/EC, 21 September 2007

This list contains hazardous substances for purposes of Directive 90/385/EEC on active implantable medical devices, particularly as regards Article 3 and Annex I (Essential Requirements). This non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Please note that Regulation (EU) 2017/745 on medical devices has repealed Directive 90/385/EEC and begun to apply from 26 May 2021. Nevertheless, Article 120 of the Regulation provides for a transitional period allowing medical devices, under specified conditions (e.g., placed on the market prior to 26 May 2021), to continue to comply with the Directive. In accordance with the fourth paragraph of Article 120, this period ends 26 May 2025.

Last updated 10 May 2024. Database contains 4753 unique substances/entries.

Filter the list

Showing 4,601 - 4,753 of 4,753 results.

Substance Name	EC No.	CAS No.	EU_BA Directive 2000/54/EC	EU REACH: List of SVHC
Perfluorobutane sulfonic acid; PFBS	206-793-1	375-73-5		yes
Perfluorohexane-1-sulphonic acid	206-587-1	355-46-4		yes
Phenanthrene	201-581-5	85-01-8		yes
Phenol, 4-nonyl-, phosphite (3:1)	608-492-4	3050-88-2		yes
Phenol, heptyl derivs.	276-743-1	72624-02-3		yes
Phenol, nonyl-, branched	291-844-0	90481-04-2		yes
Plasmodium falciparum	-	-	P Parasites
Plasmodium spp. (human and simian)	-	-	P Parasites
Plesiomonas shigelloides	-	-	B Bacteria and similar species
Polioviruses	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Polyethylene glycol mono(tert-octylph-enyl) ether9036-19-5	618-541-1	9036-19-5		yes
Porphyromonas spp.	-	-	B Bacteria and similar species
Potassium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionate	266-578-3	67118-55-2		yes
Potassium hydroxyoctaoxodizincatedichromate	234-329-8	11103-86-9		yes
Potassium perfluorohexane-1-sulphonate	223-393-2	3871-99-6		yes
Powassan	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Prevotella spp.	-	-	B Bacteria and similar species
Prospect Hill virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Proteus mirabilis	-	-	B Bacteria and similar species
Proteus penneri	-	-	B Bacteria and similar species
Proteus vulgaris	-	-	B Bacteria and similar species
Providencia alcalifaciens	-	-	B Bacteria and similar species
Providencia rettgeri	-	-	B Bacteria and similar species
Providencia spp.	-	-	B Bacteria and similar species
Pseudomonas aeruginosa	-	68583-29-9	B Bacteria and similar species
Puumala virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Pyrene	204-927-3	129-00-0		yes
Pyrochlore, antimony lead yellow This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77588.	232-382-1	8012-00-8		yes
Rabbitpox virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Rabies virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Reaction mass of 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate and 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-octyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate; reaction mass of DOTE and MOTE	915-270-3	-		yes
Reaction mass of 5-(sec-butyl)-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-(sec-butyl)-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane;Reaction mass of 5-[(2R)-butan-2-yl]-2-[(1R,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1R,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1S,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1S,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2S)-butan-2-yl]-2-[(1S,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2S)-butan-2-yl]-2-[(1S,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane	413-720-9	117933-89-8		yes
Reaction mass of 5-(sec-butyl)-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane and 5-(sec-butyl)-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane;Reaction mass of 5-[(2R)-butan-2-yl]-2-[(1R,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1R,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1S,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1S,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2S)-butan-2-yl]-2-[(1S,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2S)-butan-2-yl]-2-[(1S,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane	413-720-9	117933-89-8		yes
Reaction product of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and phenol, heptyl derivs.	-	-		yes
Reaction products of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and 4-heptylphenol, branched and linear (RP-HP)	939-460-0	1471311-26-8		yes
Respiratory syncytial virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Reuviruses	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Rhinoviruses	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Rhodococcusequi	-	-	B Bacteria and similar species
Rickettsia akari	-	-	B Bacteria and similar species
Rickettsia canada	-	-	B Bacteria and similar species
Rickettsia conorii	-	-	B Bacteria and similar species
Rickettsia montana	-	-	B Bacteria and similar species
Rickettsia prowazekii	-	-	B Bacteria and similar species
Rickettsia rickettsii	-	-	B Bacteria and similar species
Rickettsia spp.	-	-	B Bacteria and similar species
Rickettsia tsutsugamushi	-	-	B Bacteria and similar species
Rickettsia typhi	-	-	B Bacteria and similar species
Rift Valley fever	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Rocio	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Ross River virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Rubivirus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Russian spring-summer encephalitis	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Sabia virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Salmonella (other serovars)	-	-	B Bacteria and similar species
Salmonella arizonae	-	-	B Bacteria and similar species
Salmonella enteritidis	-	-	B Bacteria and similar species
Salmonella paratyphi A, B, C	-	-	B Bacteria and similar species
Salmonella typhi	-	-	B Bacteria and similar species
Salmonella typhimurium	-	68583-35-7	B Bacteria and similar species
Salts of 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionic acid	-	-		yes
Salts of Perfluorobutane sulfonic acid	-	-		yes
Salts of Perfluorohexane-1-sulfonic acid show/hide 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. With pyrrolidine (1:1) EC / List no: - \| CAS no: 1187817-57-7 Ammonium perfluorohexane-1-sulphonate EC / List no: 269-511-6 \| CAS no: 68259-08-5 Methanaminium, N,N,N-trimethyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1) EC / List no: - \| CAS no: 189274-31-5 Sulfonium, [4-[(2-methyl-1-oxo-2-propenyl)oxy]phenyl]diphenyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1), polymer with 2-ethyltricyclo[3.3.1.13,7]dec-2-yl 2-methyl-2-propenoate, 3-hydroxytricyclo[3.3.1.13,7]dec-1-yl 2-methyl-2-propenoate and tetrahydro-2-oxo-3-furanyl 2-methyl-2-propenoate EC / List no: - \| CAS no: 911027-69-5 Quinolinium, 1-(carboxymethyl)-4-[2-[4-[4-(2,2-diphenylethenyl)phenyl]-1,2,3,3a,4,8b-hexahydrocyclopent[b]indol-7-yl]ethenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) EC / List no: - \| CAS no: 1462414-59-0 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd. with N,N-diethylethanamine (1:1) EC / List no: - \| CAS no: 72033-41-1 N,N,N-tributylbutan-1-aminium tridecafluorohexane-1-sulfonate EC / List no: - \| CAS no: 108427-54-9 Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) EC / List no: - \| CAS no: 1310480-27-3 Methanaminium, N-[4-[[4-(dimethylamino)phenyl][4-(phenylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) EC / List no: - \| CAS no: 1310480-28-4 Tridecafluorohexanesulphonic acid, compound with 2,2'-iminodiethanol (1:1) EC / List no: 274-462-9 \| CAS no: 70225-16-0 Iodonium, bis[(1,1-dimethylethyl)phenyl]-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:1) (9CI) EC / List no: - \| CAS no: 866621-50-3 Sulfonium, triphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) EC / List no: - \| CAS no: 144116-10-9 Beta-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1) EC / List no: - \| CAS no: 1329995-45-0 Ethanaminium, N-[4-[[4-(diethylamino)phenyl][4-(ethylamino)-1-naphthalenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) EC / List no: - \| CAS no: 1310480-24-0 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, compd.with 2-methyl-2-propanamine (1:1) EC / List no: - \| CAS no: 202189-84-2 Dibenzo[k,n][1,4,7,10,13]tetraoxathiacyclopentadecinium, 19-[4-(1,1-dimethylethyl)phenyl]-6,7,9,10,12,13-hexahydro-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) EC / List no: - \| CAS no: 928049-42-7 Iodonium, diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) EC / List no: - \| CAS no: 153443-35-7 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, scandium(3+) salt (3:1) EC / List no: - \| CAS no: 350836-93-0 Gamma-Cyclodextrin, compd. with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid ion(1-)(1:1) EC / List no: - \| CAS no: 1329995-69-8 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, lithium salt (1:1) EC / List no: - \| CAS no: 55120-77-9 Phosphonium, triphenyl(phenylmethyl)-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) EC / List no: - \| CAS no: 1000597-52-3 Sulfonium, (4-methylphenyl)diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) EC / List no: - \| CAS no: 910606-39-2 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, gallium salt (9CI) EC / List no: - \| CAS no: 341035-71-0 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, zinc salt EC / List no: - \| CAS no: 70136-72-0 Potassium perfluorohexane-1-sulphonate EC / List no: 223-393-2 \| CAS no: 3871-99-6 Iodonium, bis[4-(1,1-dimethylpropyl)phenyl]-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic EC / List no: - \| CAS no: 421555-74-0 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, sodium salt EC / List no: - \| CAS no: 82382-12-5 Sulfonium, [4-[(2-methyl-1-oxo-2-propen-1-yl)oxy]phenyl]diphenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) EC / List no: - \| CAS no: 911027-68-4 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, yttrium(3+) salt (3:1) EC / List no: - \| CAS no: 41242-12-0 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, neodymium(3+) salt (3:1) EC / List no: - \| CAS no: 41184-65-0 Sulfonium, tris[4-(1,1-dimethylethyl)phenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) EC / List no: - \| CAS no: 425670-70-8 1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, cesium salt (1:1) EC / List no: - \| CAS no: 92011-17-1 Sulfonium, (thiodi-4,1-phenylene)bis[diphenyl-, salt with 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonic acid (1:2) EC / List no: - \| CAS no: 421555-73-9 Iodonium, bis[4-(1,1-dimethylethyl)phenyl]-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) EC / List no: - \| CAS no: 213740-81-9 N,N,N-triethylethanaminium tridecafluorohexane-1-sulfonate EC / List no: - \| CAS no: 108427-55-0 Sulfonium, bis(4-methylphenyl)phenyl-, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-hexanesulfonate (1:1) EC / List no: - \| CAS no: 341548-85-4	-	-		yes
Sandfly fever	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Sarcocystis suihominis	-	-	P Parasites
Scedosporium apiospermum	-	-	F Fungi
Scedosporium prolificans (inflatum)	-	-	F Fungi
Schistosoma haematobium	-	-	P Parasites
Schistosoma intercalatum	-	-	P Parasites
Schistosoma japonicum	-	-	P Parasites
Schistosoma mansoni	-	-	P Parasites
Schistosoma mekongi	-	-	P Parasites
Semliki Forest virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Seoul virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Serpulina spp.	-	-	B Bacteria and similar species
Severe acute respiratory syndrome coronavirus 2	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Shigella boydii	-	-	B Bacteria and similar species
Shigella dysenteriae (Type 1)	-	-	B Bacteria and similar species
Shigella dysenteriae, other than Type 1	-	-	B Bacteria and similar species
Shigella flexneri	-	-	B Bacteria and similar species
Shigella sonnei	-	-	B Bacteria and similar species
Silicic acid (H2Si2O5), barium salt (1:1), lead-doped	272-271-5	68784-75-8		yes
Silicic acid, lead salt	234-363-3	11120-22-2		yes
Sin Nombre	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Sindbis virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
SIV	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Sodium dichromate	616-541-6	7789-12-0		yes
Sodium perborate; perboric acid, sodium salt;sodium perborate; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];sodium perborate; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	239-172-9	15120-21-5		yes
Sodium peroxometaborate;sodium peroxometaborate; sodium peroxoborate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];sodium peroxometaborate; sodium peroxoborate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	231-556-4	7632-04-4		yes
Sporothrix schenckii	-	-	F Fungi
St Louis encephalitis	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Staphylococcusaureus	-	-	B Bacteria and similar species
Streptobacillus moniliformis	-	-	B Bacteria and similar species
Streptococcus pneumoniae	-	-	B Bacteria and similar species
Streptococcus pyogenes	-	-	B Bacteria and similar species
Streptococcus spp.	-	-	B Bacteria and similar species
Streptococcus suis	-	-	B Bacteria and similar species
Strongyloides spp.	-	-	P Parasites
Strongyloides stercoralis	-	-	P Parasites
Sulfuric acid, cadmium salt (1:1), hydrate (3:8)	616-572-5	7790-84-3		yes
Sulfurous acid, lead salt, dibasic	263-467-1	62229-08-7		yes
Sulphuric acid, cadmium salt (1:1), unspecified hydration rate	626-360-4	15244-35-6		yes
Taenia saginata	-	-	P Parasites
Taenia solium	-	-	P Parasites
Terphenyl, hydrogenated	262-967-7	61788-32-7		yes
Terphenyl, hydrogenated	262-967-7	61788-32-7		yes
Tetraethyllead	201-075-4	78-00-2		yes
Tetralead trioxide sulphate	235-380-9	12202-17-4		yes
Tick-borne orthomyxoviridae: Dhori and Thogoto	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Tonate virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Toroviridae	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Toscana virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Toxocara canis	-	-	P Parasites
Toxoplasma gondii	-	-	P Parasites
Treponema carateum	-	-	B Bacteria and similar species
Treponema pallidum	-	-	B Bacteria and similar species
Treponema pertenue	-	-	B Bacteria and similar species
Treponema spp.	-	-	B Bacteria and similar species
Trichinella spiralis	-	-	P Parasites
Trichophyton rubrum	-	-	F Fungi
Trichophyton spp.	-	-	F Fungi
Trichuristrichiura	-	-	P Parasites
Tricosafluorododecanoic acid	206-203-2	307-55-1		yes
Tridecafluorohexanesulphonic acid, compound with 2,2'-iminodiethanol (1:1)	274-462-9	70225-16-0		yes
Trilead bis(carbonate)dihydroxide	215-290-6	1319-46-6		yes
Trilead diarsenate	222-979-5	3687-31-8		yes
Trilead dioxide phosphonate	235-252-2	12141-20-7		yes
Tris(4-nonylphenyl, branched) phosphite show/hide Phenol, p-sec-nonyl-, phosphite EC / List no: - \| CAS no: 106599-06-8 Phenol, 4-nonyl-, phosphite (3:1) EC / List no: 608-492-4 \| CAS no: 3050-88-2 tris(4-nonylphenyl, branched) phosphite EC / List no: 701-028-2 \| CAS no: - Phenol, p-isononyl-, phosphite (3:1) EC / List no: - \| CAS no: 31631-13-7 Tris(nonylphenyl) phosphite EC / List no: 247-759-6 \| CAS no: 26523-78-4	799-976-5	-		yes
Trypanosoma brucei brucei	-	-	P Parasites
Trypanosoma brucei gambiense	-	-	P Parasites
Trypanosoma brucei rhodesiense	-	-	P Parasites
Trypanosoma cruzi	-	-	P Parasites
Vaccinia virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Variant Creutzfeldt-Jakob disease	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Variola (major and minor) virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Venezuelan equine encephalomyelitis	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Vesicular stomatitis virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Vibrio cholerae (including El Tor)	-	-	B Bacteria and similar species
Vibrio parahaemolyticus	-	-	B Bacteria and similar species
Vibrio spp.	-	-	B Bacteria and similar species
Wesselsbron virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
West Nile fever virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Western equine encephalomyelitis	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Whitepox virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Wuchereria bancrofti	-	-	P Parasites
Yatapox virus	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Yellow fever	-	-	V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Yersinia enterocolitica	-	-	B Bacteria and similar species
Yersinia pestis	-	-	B Bacteria and similar species
Yersinia pseudotuberculosis	-	-	B Bacteria and similar species
Yersinia spp.	-	-	B Bacteria and similar species
Zirconia Aluminosilicate Refractory Ceramic Fibres	936-037-2	-		yes
α,α-Bis[4-(dimethylamino)phenyl]-4 (phenylamino)naphthalene-1-methanol; C.I. Solvent Blue 4	229-851-8	6786-83-0		yes

Showing 4,601 - 4,753 of 4,753 results.

Export search results to:

EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1

EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1

Active Implantable Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 90/385/EEC on Active Implantable Medical Devices, 20 July 1990, amended by Directive 2007/47/EC, 21 September 2007

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 10 May 2024. Database contains 4753 unique substances/entries.

Footer Nav Items